Login / Signup

Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.

Paul DeschampsMufaddal MoonimDeepti H RadiaNatalia Curto-GarciaClaire WoodleySarah BassionyJennifer O'SullivanPatrick HarringtonKavita RajYvonne FrancisShahram KordastiSahra AliClaire N HarrisonDonal P McLornan
Published in: British journal of haematology (2021)
Myeloproliferative neoplasm-unclassifiable (MPN-U) presents an MPN-type phenotype that fails to meet diagnostic criteria for other MPN variants. Variability in the clinicopathological phenotypes presents many challenges. Amongst a registry cohort of 1512 patients with MPN, 82 with MPN-U were included, with a median (range) age of 49·7 (13-79) years. Albeit heterogeneous, common presentation features included raised lactate dehydrogenase, thrombocytosis and clustered/pleomorphic megakaryocytes on trephine biopsy. Thrombosis was common (21%), necessitating vigilance. The median event-free survival was 11·25 years (95% confidence interval 9·3-not reached), significantly shortened in cases with lower platelet counts (<500 × 109 /l) and a leucocytosis (≥12 × 109 /l) at presentation. Generation of potential MPN-U prognostic scores is required.
Keyphrases
  • free survival
  • low grade
  • primary care
  • pulmonary embolism
  • risk assessment
  • case report
  • gene expression
  • dna methylation
  • peripheral blood
  • cross sectional
  • copy number
  • climate change
  • human health